[ad_1]
The media office of the Ministry of Public Health stated in a statement that, “since the announcement of the trial of several vaccines in the world, it has contacted the relevant authorities such as the Russian embassy, the Chinese embassy and international pharmaceutical companies , which have a presence in Lebanon and requested that all the information related to vaccines be provided to them, to be evaluated and possible to authorize emergency use.
He noted that “based on the data available to the Ministry of Public Health, the most important of which is the effectiveness and approval of the vaccine by international references, which is the basis for registering and approving any drug in Lebanon, the Pfizer vaccine that met these controls was chosen and obtained an emergency use license. Authorization for use, also obtained approval from the Scientific Committee of the Ministry of Health, and Lebanon will receive the vaccine in mid-February in batches, so 15% of citizens will be covered, “noting that” the Pfizer vaccine is currently used in the United States of America, Great Britain. In some other European countries, first-line healthcare workers are vaccinated as a first step.
He explained that, “Simultaneously, the ministry negotiated with the global platform Kovacs to obtain additional vaccines that will then be approved by the World Health Organization to cover an additional 20% of citizens, respectively, according to the plan of the national supervisory committee of Corona vaccines, and within the strategy adopted by the Ministry of Public Health, to accelerate the registration of any vaccine that meets the standards approved without discretion to supply it through the private sector within the current Lebanese laws on registration and marketing .
[ad_2]
